Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes predicts survival after immune checkpoint inhibitor therapy across multiple cancer types.

Authors

null

Jeanne Shen

Department of Pathology, Stanford University School of Medicine, Stanford, CA

Jeanne Shen , Taebum Lee , Jun-Eul Hwang , Yoon-La Choi , Se-Hoon Lee , Hyojin Kim , Jin-haeng Chung , Stephanie Bogdan , Maggie Huang , Tyler Raclin , George A. Fisher Jr., Sergio Pereira , Seonwook Park , Minuk Ma , Donggeun Yoo , Seunghwan Shin , Kyunghyun Paeng , Chan-Young Ock , Tony S. K. Mok , Yung-Jue Bang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2607)

DOI

10.1200/JCO.2021.39.15_suppl.2607

Abstract #

2607

Poster Bd #

Online Only

Abstract Disclosures